Ulisse BioMed Competitors and Similar CompaniesClear all
Ulisse BioMed's competitors and similar companies include Elektrofi, ChemoSen3D, Novacyt and Kallyope.
 Ulisse BioMed Ulisse BioMed is a healthcare biotech company that provides diagnostic platforms and products. |  ChemoSen3D ChemoSen3D (formerly Nano3D Biosciences) is a company that develops an approach to personalized treatment to deliver recommendations. |  Novacyt Novacyt is active in developing, manufacturing and marketing advanced and innovative solutions for cytology. | |||
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date 2008 | Founding Date N/A | Founding Date 2015 |
Type | Type Public | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Udine, IT HQ | Locations Boston, US HQ Boston, US Boston, US Cambridge, US | Locations Houston, US HQ | Locations Vélizy-Villacoublay, FR HQ Camberley, GB Chandler's Ford, GB | Locations New York, US HQ |
Employees | Employees 8 | Employees 961% decrease | Employees 5 | Employees 234 | Employees 70 |
Valuation ($) | Valuation ($) 22.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 49 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €768k (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) £20m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €1.8m (FY, 2024) | Cost of goods N/A | Cost of goods N/A | Cost of goods £7.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit (€597k) (FY, 2024) | Gross profit N/A | Gross profit N/A | Gross profit £14.4m (FY, 2025) | Gross profit N/A |
Net income | Net income (€5.9m) (FY, 2024) | Net income N/A | Net income N/A | Net income (£22.9m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 250k (about 16 years ago) | Latest funding round N/A | Latest funding round $ 112m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 11.6m | Total funding raised $ 243m |
For sources of this data, please see the company profile
View Company Profiles
Elektrofi
HQ
Boston, US
Employees
96↓ 1% decrease
Elektrofi is a company that provides biopharmaceutical formulation technology solutions.
View companyChemoSen3D
HQ
Houston, US
Employees
5
ChemoSen3D (formerly Nano3D Biosciences) is a company that develops an approach to personalized treatment to deliver recommendations.
View companyNovacyt
HQ
Vélizy-Villacoublay, FR
Employees
234
Novacyt is active in developing, manufacturing and marketing advanced and innovative solutions for cytology.
View company